Mortality After Incident Cancer in People With and Without Type 2 Diabetes Featured Article: Craig J. Currie, Ph.D., Chris D. Poole, Ph.D., Sara Jenkins-Jones,

Slides:

Advertisements

Similar presentations

What do hospitals do for patient outcomes? 30 day mortality after heart attack Future of healthcare in Europe 13 May 2011.

Advertisements

THE DIABETES PREVENTION PROGRAM RESEARCH GROUP*

Introduction to UK GO data GPRD: General Practice Research Database THIN: Health Improvement Network Some new data too.

Severe Hypoglycemia and Mortality After Cardiovascular Events for Type 1 Diabetic Patients in Sweden Featured Article: Tom W.C. Lung, Dennis Petrie, William.

Liraglutide and the Preservation of Pancreatic β-Cell Function in Early Type 2 Diabetes: The LIBRA Trial Featured Article: Ravi Retnakaran, Caroline K.

Clinical Relevance of HER2 Overexpression/Amplification in Patients with Small Tumor Size and Node-Negative Breast Cancer Curigliano G et al. J Clin Oncol.

Hazard of incident coronary heart disease by diabetes status, with or without elevation of troponin T No diabetes Pre- diabetes Diabetes No diabetes Pre-

Population-based Study Of Giant Cell Tumour Of The Bone In Sweden Justyna Amelio, 1 Julia Sandberg, 2 Rohini K. Hernandez, 3 Patrik Sobocki, 4 Scott Stryker,

Vitamin D Levels Predict All-Cause and Cardiovascular Disease Mortality in Subjects With the Metabolic Syndrome Featured Article: G. Neil Thomas, Ph.D.,

The influence of Breast Cancer Pay for Performance Initiatives on breast cancer survival and performance measures: a pilot study in Taiwan Raymond NC Kuo,

Individualizing Targets and Tactics for High- Risk Patients With Type 2 Diabetes Practical lessons from ACCORD and other cardiovascular trials Featured.

Rapid Rise in Hypertension and Nephropathy in Youth With Type 2 Diabetes The TODAY clinical trial Featured Article: TODAY Study Group* Diabetes Care Volume.

Prostate Cancer: A Case for Active Surveillance Philip Kantoff MD Dana-Farber Cancer Institute Professor of Medicine Harvard Medical School.

Translational Science in Cancer Health Disparities Research Peter Ujhazy, M.D., Ph.D. Program Director Translational Research Program Division of Cancer.

Impact of Socioeconomic Status on Cardiovascular Disease and Mortality in 24,947 Individuals With Type 1 Diabetes Featured Article: Araz Rawshani, Ann-Marie.

Metabolic Syndrome and Risk of Cancer: A Systematic Review and Meta-Analysis Featured Article: Katherine Esposito, M.D., Ph.D., Paolo Chiodini, Ph.D.,

Diabetes in Cancerland Edwin Gale. This Meeting Thanks to: The Steno team The Danish Cancer Society The EASD.

Early Loss of the Glucagon Response to Hypoglycemia in Adolescents With Type 1 Diabetes Featured Article: Aris Siafarikas, F.R.A.C.P., M.D., Robert J.

Risk of Dementia in Seniors with Newly Diagnosed Diabetes: A Population-Based Study Featured Article: Nisha Nigil Haroon, Peter C. Austin, Baiju R. Shah,

Higher Incidence of Venous Thromboembolism (VTE) in the Outpatient versus Inpatient Setting Among Patients with Cancer in the United States Khorana A et.

Long-Term Complications and Mortality in Young-Onset Diabetes Type 2 diabetes is more hazardous and lethal than type 1 diabetes Featured Article: Maria.

Diabetes and Cause-Specific Mortality in a Prospective Cohort of One Million U.S. Adults Featured Article: Peter T. Campbell, Ph.D., Christina C. Newton,

Gray Zone Lymphoma (GZL) with Features Intermediate between Classical Hodgkin Lymphoma (cHL) and Diffuse Large B-Cell Lymphoma (DLBCL): A Large Retrospective.

Chronic diseases as tracer conditions in international benchmarking of health systems: the example of diabetes 1 European Centre on Health of Societies.

Hsia J et al. J Am Coll Cardiol 2011;57: Baseline Characteristics by Treatment Group and Attained LDL-C Hsia J et al. J Am Coll Cardiol 2011;57:

Shalev V, et al. Arch Intern Med 2009; 169:

Helicobacter pylori Infection Is Associated With an Increased Rate of Diabetes Featured Article: Christie Y. Jeon, Sc.D., Mary N. Haan, Dr.PH., Caroline.

1 CONFIDENTIAL – DO NOT DISTRIBUTE ARIES mCRC: Effectiveness and Safety of 1st- and 2nd-line Bevacizumab Treatment in Elderly Patients Mark Kozloff, MD.

Results Methods Abstract Number 69 Objectives 1.Nephrol Dial Transplant (2011) 26: 537–543 2.J Support Oncol 2011;9:149–155 3.N Engl J Med. 2009; 361:1627–1638.

Clinical and Economic Benefits Associated With the Achievement of Both HbA1c and LDL Cholesterol Goals in Veterans With Type 2 Diabetes Featured Article:

Childhood and Adult Secondhand Smoke and Type 2 Diabetes in Women Featured Article: Martin Lajous, M.D., S.C.D., Laura Tondeur, M.S., Guy Fagherazzi, P.H.D.,

Trends in Death Rates Among U.S. Adults With and Without Diabetes Between 1997 and 2006 Featured Article: Edward W. Gregg, Ph.D., Yiling J. Cheng, Ph.D.,

National Cancer Intelligence Network Outcome and the effect of age in 1318 patients with synovial sarcoma: Report from the National Cancer Intelligence.

High Concentrations of AGE-LDL and Oxidized LDL in Circulating Immune Complexes Are Associated With Progression of Retinopathy in Type 1 Diabetes Featured.

Short- and Long-Term Mortality After Myocardial Infarction in Patients With and Without Diabetes Featured Article: Sjoerd T. Nauta, M.S.C., Jaap W. Deckers,

Response to Antiretroviral Treatment In an Ethiopian Hospital Samuel Hailemariam, MD, MPH; J Allen McCutchan, MD, MSc Meaza Demissie, MD, PMH, PHD; Alemayehu.

Celiac Disease Increases Risk of Thyroid Disease in Patients With Type 1 Diabetes: A Nationwide Cohort Study Featured Article: Matthew Kurien, Kaziwe Mollazadegan,

Evaluating the Clinical Outcomes of Sixty-Three Patients Treated with Gamma Knife as Salvage Therapy for Glioblastoma Multiforme Erik W Larson, Halloran.

Severe Hypoglycemia Identifies Vulnerable Patients With Type 2 Diabetes at Risk for Premature Death and All-Site Cancer: The Hong Kong Diabetes Registry.

F. 정 회 훈 Am J Gastroenterol 2012;107:46-52 Risk of Hepatocellular Carcinoma in Diabetic Patients and Risk Reduction Associated With Anti-Diabetic Therapy:

Statin Use and Reduced Cancer-Related Mortality Sune F. Nielsen, Ph.D., Børge G. Nordestgaard, M.D., D.M.Sc. New Engl J Med 2012;367: november.

Papillary Thyroid Cancer Treated at the Mayo Clinic, 1946 Through 1970: Initial Manifestations, Pathologic Findings, Therapy, and Outcome WILLIAM M.

Association between sleep apnea, snoring, incident cardiovascular events and all-cause mortality in an adult population: MESA Joseph Yeboah, Susan Redline,

The ADEMEX Trial Adequacy of PD in Mexico Reference

Presenter: Wen-Ching Lan Date: 2018/08/01

Bleeding and cancer risk in patients with vascular disease COMPASS Steering Committee and Investigators.

Diabetes hazard rates by number of visits with reported statin use.

Effects of a Nationwide Predialysis Educational Program on Modality Choice, Vascular Access, and Patient Outcomes Eduardo Lacson, MD, MPH, Weiling Wang,

Covering the Cover Gastroenterology

ASCOT-BPLA: Primary and secondary end points

Papillary Thyroid Cancer Treated at the Mayo Clinic, 1946 Through 1970: Initial Manifestations, Pathologic Findings, Therapy, and Outcome WILLIAM M.

Incidence of type 2 diabetes after bariatric surgery: population-based matched cohort study Helen Booth, MSc, Omar Khan, FRCS, Prof Toby Prevost, PhD,

Impact of Hepatitis C, HIV, or Both on Survival in Veterans in Care Before and After the Introduction of HAART (1996) SL Fultz, MD, MPH CH Chang, PhD AA.

Published online September 20, 2017 by JAMA Surgery

Volume 8, Issue 12, Pages (December 2011)

Kaplan Meier survival curve free of CV events and Cox proportional hazards model. Comparison of ATPIII and IDF classifications Kaplan Meier survival.

The origins of multidisciplinary cancer care

Cumulative incidences of events, according to glucose-control strategy

Baseline Characteristics According to Sex

by Pauline Williams, Peter Murchie, and Christine Bond

Megan Eguchi, MPh Sana karam, md, phd

The estimated survival function using the Cox proportional hazards model and the mean value covariate pattern (days to recurrence, net tumor volume) for.

HRs for prostate cancer by medication status.

Forest plot and pooled estimates of the effect of NAFLD on the risk of incident diabetes in 16 eligible studies, stratified by length of follow-up (FU)

Alcohol, Other Drugs, and Health: Current Evidence

Kaplan-Meier survival analysis for all-cause and CVD mortality in 2,823 type 2 diabetic patients stratified by CKD according to each creatinine-based equation.

Colorectal cancer survival disparities in California

Nadia Howlader, PhD National Cancer Institute

New dialysis starts in the United States by year in patients with and without diagnosis of diabetes. New dialysis starts in the United States by year in.

Pooled estimate of relative risk and 95% CIs of colorectal cancer associated with metformin therapy based on four studies comprising 107,961 diabetic patients.

Presentation transcript:

Mortality After Incident Cancer in People With and Without Type 2 Diabetes Featured Article: Craig J. Currie, Ph.D., Chris D. Poole, Ph.D., Sara Jenkins-Jones, M.Sc., Edwin A.M. Gale, M.D., Jeffrey A. Johnson, Ph.D., Christopher Ll. Morgan, M.Sc. Diabetes Care Volume 35: 299–304 February, 2012

Study Objectives Examined the hypotheses that: Survival after a diagnosis of solid-tumor cancer is reduced in those with diabetes when compared with those without diabetes Treatment with metformin influences survival after cancer diagnosis Currie C et al. Diabetes Care 2012;35:

Study Design Data obtained from >350 U.K. primary care practices in a retrospective cohort study Individuals with or without diabetes who developed a first tumor after January 1990 were identified and records were followed to December 2009 Diabetes further stratified by treatment regimen Cox proportional hazards models used to compare all-cause mortality from all cancers and from specific cancers Currie C et al. Diabetes Care 2012;35:

Conclusions Type 2 diabetes was associated with poorer prognosis after incident cancer, but association varied according to diabetes therapy and cancer site Metformin was associated with survival benefit in comparison with other treatments for diabetes and in comparison with a nondiabetic population Currie C et al. Diabetes Care 2012;35: